Cargando…
Ki‐67 index, progesterone receptor expression, histologic grade and tumor size in predicting breast cancer recurrence risk: A consecutive cohort study
BACKGROUND: The 21‐gene recurrence score (RS) assay has been recommended by major guidelines for treatment decision in hormone receptor (HR)‐positive early breast cancer (EBC). However, the genomic assay is not accessible and affordable worldwide. Alternatively, an increasing number of studies have...
Autores principales: | Zhang, Yanna, Zhou, Yidong, Mao, Feng, Yao, Ru, Sun, Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170660/ https://www.ncbi.nlm.nih.gov/pubmed/32291973 http://dx.doi.org/10.1002/cac2.12024 |
Ejemplares similares
-
Can Histological Grade and Mitotic Index Replace Ki67 to Determine Luminal Breast Cancer Subtypes?
por: Oddó, David, et al.
Publicado: (2018) -
Correlation Between Apparent Diffusion Coefficient and the Ki-67 Proliferation Index in Grading Pediatric Glioma
por: Yao, Rong, et al.
Publicado: (2023) -
Automated quantification of Ki-67 index associates with pathologic grade of pulmonary neuroendocrine tumors
por: Wang, Hai-Yue, et al.
Publicado: (2019) -
Association between Ki-67 Labeling index and Histopathological Grading of Glioma in Indonesian Population
por: Theresia, Emilia, et al.
Publicado: (2020) -
Lung carcinoid tumours: histology and Ki‐67, the eternal rivalry
por: Centonze, Giovanni, et al.
Publicado: (2022)